1290 related articles for article (PubMed ID: 19174039)
1. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
[TBL] [Abstract][Full Text] [Related]
3. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
4. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients.
Chan HL; Wu JC; Chan FK; Choi CL; Ching JY; Lee YT; Leung WK; Lau JY; Chung SC; Sung JJ
Gastrointest Endosc; 2001 Apr; 53(4):438-42. PubMed ID: 11275883
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.
Bobrzyński A; Konturek PC; Konturek SJ; Płonka M; Bielański W; Karcz D
Med Sci Monit; 2005 Mar; 11(3):CR132-5. PubMed ID: 15735566
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
Chen TS; Luo JC; Chang FY
J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors for peptic ulcer bleeding].
Søberg T; Hofstad B; Sandvik L; Johansen M; Lygren I
Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1135-9. PubMed ID: 20531499
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of bleeding peptic ulcers: a prospective study.
Liu NJ; Lee CS; Tang JH; Cheng HT; Chu YY; Sung KF; Lin CH; Tsou YK; Lien JM; Chen PC; Chiu CT; Cheng CL
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e340-7. PubMed ID: 17944885
[TBL] [Abstract][Full Text] [Related]
9. Diagnostics of Helicobacter pylori infection in patients with peptic ulcer bleeding.
Peitz U; Leodolter A; Wex T; Schütze D; Wolle K; Welte T; Günther T; Schmidt U; Malfertheiner P
Z Gastroenterol; 2004 Feb; 42(2):141-6. PubMed ID: 14963786
[TBL] [Abstract][Full Text] [Related]
10. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
11. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development.
Laine L; Marin-Sorensen M; Weinstein WM
Am J Gastroenterol; 1992 Oct; 87(10):1398-402. PubMed ID: 1415094
[TBL] [Abstract][Full Text] [Related]
14. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
15. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
[TBL] [Abstract][Full Text] [Related]
16. Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication.
Bobrzyński A; Beben P; Budzyński A; Bielański W; Plonka M; Konturek S
Med Sci Monit; 2002 Aug; 8(8):CR554-7. PubMed ID: 12165741
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
18. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
Venerito M; Malfertheiner P
Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184
[TBL] [Abstract][Full Text] [Related]
20. [Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori].
Amendola M; Farias R; Katz J; Luna P; Ianella M; Musi A; Boerr L; Valero J; Kogan Z; Corti R
Acta Gastroenterol Latinoam; 1999; 29(2):47-50. PubMed ID: 10491714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
